Cargando…

The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer

Breast cancer is a kind of malignant tumor that seriously endangers women's life and health. Once diagnosed, most patients will receive a combination of treatments to achieve a cure. However, breast cancer is a heterogeneous disease. Even with the same clinical stage and pathological features,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Keyu, Wu, Jiayi, Fang, Ziru, Shao, Xiying, Wang, Xiaojia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Screening, Diagnosis, and Treatment of Breast Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486269/ https://www.ncbi.nlm.nih.gov/pubmed/36976899 http://dx.doi.org/10.1177/15330338221117402

Ejemplares similares

Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Prospective Observational Cohort Study
por: Thanestada, Jirawat, et al.
Publicado: (2022)

Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population
por: Zhang, Yusi, et al.
Publicado: (2022)

A Realistic Breast Phantom Proposal for 3D Image Reconstruction in Digital Breast Tomosynthesis
por: Polat, Adem, et al.
Publicado: (2022)

The use of Hybrid Techniques in Whole-Breast Radiotherapy: A Systematic Review
por: Karaca, Sibel
Publicado: (2022)

Review on Deep Learning-Based CAD Systems for Breast Cancer Diagnosis
por: Arun Kumar, S., et al.
Publicado: (2023)

Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
por: Zhang, Hongyi, et al.
Publicado: (2022)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis
por: Zhang, Duo, et al.
Publicado: (2022)

Impact of Sentinel Lymph Node Biopsy on Treatment Decision and Survival in Patients Aged ≥70 Years with Breast Cancer: A Retrospective Study
por: Gu, Chongshan, et al.
Publicado: (2022)

Tracing 2D Growth of Pancreatic Tumoroids Using the Combination of Image Processing Techniques and Mini-Opto Tomography Imaging System
por: Akbaba, Cihat Ediz, et al.
Publicado: (2023)

Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC
por: Wang, Hao, et al.
Publicado: (2022)

The Regulatory Mechanism and Research Progress of Ferroptosis in Gastric Cancer
por: Zhang, Zaibo, et al.
Publicado: (2023)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022)

The Applications and Potential Developments of Ultrasound in Oral Cancer Management
por: Lo, Wu-Chia, et al.
Publicado: (2022)

Tubulin Alpha-1b as a Potential Biomarker for Lung Adenocarcinoma Diagnosis and Prognosis
por: Pang, Xue-Li, et al.
Publicado: (2023)

Enrichment of Circulating Tumor Cells of Lung Cancer and Correlation With Serum Leukomonocyte and Tumor Biomarkers: A Retrospective Study
por: Mei, Zhou-Fang, et al.
Publicado: (2023)

The Effectiveness of Population Mass Screening to Oral Cancer: A Simulation Study
por: Su, Chiu-Wen, et al.
Publicado: (2022)

The Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio on Survival Outcome for Patients With Locally Advanced Oral Squamous Cell Carcinoma
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Quantitative Measurement of Perineural Invasion for Prognosis Analysis of Oral Cavity Cancer Treated by Radical Surgery With or Without Adjuvant Therapy
por: Fan, Kang-Hsing, et al.
Publicado: (2023)

Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study
por: Liu, Yuting, et al.
Publicado: (2022)

Compute Tomography Radiomics Analysis on Whole Pancreas Between Healthy Individual and Pancreatic Ductal Adenocarcinoma Patients: Uncertainty Analysis and Predictive Modeling
por: Wang, Shuo, et al.
Publicado: (2022)

The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
por: Dong, Peng, et al.
Publicado: (2022)

Predictors of Readmission After Pulmonary Resection in Patients With Lung Cancer: A Systematic Review and Meta-analysis
por: Liu, Jie, et al.
Publicado: (2022)

Systemic and Local Effects Among Patients With Betel Quid-Related Oral Cancer
por: Chuang, Hui-Ching, et al.
Publicado: (2022)

Safety and Efficacy of Carbon Nanoparticle-Labeled Lymph Node Dissection in Radical Resection of Gastric Cancer: A Systematic Review and Meta-Analysis
por: Zhu, Chenglou, et al.
Publicado: (2023)

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China
por: Li, Tao, et al.
Publicado: (2023)

Bronchial Artery Chemoembolization With Radiopaque Doxorubicin Eluding Beads in Patients With Malignant Hemoptysis from Metastatic Lung Cancer
por: Nezami, Nariman, et al.
Publicado: (2022)

Antibodies Against Epstein–Barr Virus as Disease Markers of Gastric Cancer: A Systematic Review
por: Fontes-Lemus, José I., et al.
Publicado: (2023)

Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer
por: Yu, Limeng, et al.
Publicado: (2023)

Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer
por: Mansur, Arian, et al.
Publicado: (2023)

Cervical Screening Practices and Outcomes for Young Women in Response to Changed Guidelines in Calgary, Canada, 2007–2016
por: Sayed, Sayeeda Amber, et al.
Publicado: (2020)

Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review
por: Bonde, Jesper, et al.
Publicado: (2020)

The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients
por: Butler-Xu, Yiqing Shirley, et al.
Publicado: (2018)

Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies
por: Abuhadra, Nour, et al.
Publicado: (2022)

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer
por: Kadakia, Kunal C., et al.
Publicado: (2016)

The Association Between Medication Use in Older Women with Early-Stage Operable Primary Breast Cancer and Decision Regarding Primary Treatment
por: Tse, Natalie, et al.
Publicado: (2023)

Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma
por: Huang, Fei, et al.
Publicado: (2022)

Tumor Targeting by Conditioned Medium Derived From Human Amniotic Membrane: New Insight in Breast Cancer Therapy
por: Jafari, Ameneh, et al.
Publicado: (2021)

Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study
por: Litton, Jennifer K, et al.
Publicado: (2023)

Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec
por: Hassan, Saima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3otn00f4gd6si6kikvsij0t5je